Trial intelligence / Profile preview

Hyalgan after Proximal Tibial Osteotomy for Knee OA

NCT01267214Phase 2Completed

Sponsor
TRB Chemedica
Start
Feb 2009
Primary completion
Feb 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of sodium hyaluronate in osteoarthritis (OA), sponsored by TRB Chemedica. Started Feb 2009; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT01267214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01267214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call